350 rub
Journal №10 for 2012 г.
Article in number:
Inculin-like Growth Factors in Breast Cancer Patients - Serum
Keywords: IGF 1 IGF 2 breast cancer
Authors:
A.V. Masliaev, O.I. Kostyleva, E.S. Gershtein, V.D. Ermilova, V.M. Gritskevich, S.M. Portnoy
Abstract:
The alterations of JGF-signaling system are involved in breast cancer pathogenesis. Insulin-like growth factors 1 and 2 (IGF 1 and IGF 2) were measured by ELISA techniques in blood serum of 79 primary breast cancer patients and 16 control practically healthy women. No links was found between serum levels of IGF 1 and 2 and TNM criteria of breast cancer. The differencies were shown between serum IGFs levels depending on reproductive and RE, RP, HER2 statues of breast cancer patients.
Pages: 16-20
References
  1. Герштейн Е.С., Кушлинский Н.Е. Современные представления о механизмах передачи сигналов факторов роста как основа эффективной молекулярно-направленной противоопухолевой терапии // Вопросы биологической, медицинской и фармацевтической химии. 2007. № 1. С. 4-9.
  2. Frasca F., Pandini G., Sciacca L. et al. The role of insulin receptors and IGF-I receptors in cancer and other diseases // Arch. Physiol. Biochem. 2008. V. 114. № 1. P. 23-37.
  3. Grimberg A. Mechanisms by which IGF-I may promote cancer // Cancer Biol. Ther. 2003. V. 2. № 6. P. 630-635.
  4. Hartog H., Wesseling J., Boezen H.M. et al. The insulin-like growth factor 1 receptor in cancer: old focus, new future // Eur. J. Cancer. 2007. V. 43. № 13. P. 1895-1904.
  5. Laviola L., Natalicchio A., Giorgino F. The IGF-I signaling pathway // Curr. Pharm. Des. 2007. V. 13. № 7. P. 663-669.
  6. Pavelić J., Matijević T., Knezević J. Biological & physiological aspects of action of insulin-like growth factor peptide family // Indian J. Med. Res. 2007. V. 125. № 4. P. 511-522.
  7. Pollak M.N., Schernhammer E.S., Hankinson S.E. Insulin-like growth factors and neoplasia // Nat. Rev. Cancer. 2004. V. 4. P. 505-518.
  8. Yakar S., Leroith D., Brodt P. The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models // Cytokine Growth Factor Rev. 2005. V. 16. P. 407-420.
  9. Chen C., Lewis S.K., Voigt L.F. et al. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein-3, and insulin // Cancer. 2004. V. 103. № 1. P. 76-84.
  10. Schernhammer E.S., Holly J.M, Hunter D.J. et al. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II // Endocr. Relat. Cancer. 2006. V.13. № 2. P. 583-592.
  11. EpplerE., Zapf1 J., Bailer N. et al. IGF-I in human breast cancer: low differentiation stage is associated with decreased IGF-I content // Eur. J. Endocrinol. 2002. V. 146. P. 813-821.
  12. Belfiore A., Frasca F. IGF and insulin receptor signaling in breast cancer // J. Mammary Gland Biol. Neoplasia. 2008. V. 13. № 4. P. 381-406.
  13. Key T.J., Appleby P.N., Reeves GK., Roddam A.W. et al. Endogenous Hormones and Breast Cancer Collaborative Group, Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies // Lancet Oncol.2010. V. 11. № 6. P. 530-542.
  14. Moschos S.J., Mantzoros C.S. The role of the IGF system in cancer: from basic to clinical studies and clinical applications  // Oncology. 2002. V. 64. P. 317-332.
  15. Platz E.A., Pollak M.N., Leitzmann M.F. et al. Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era // Cancer Causes Control. 2005. V. 16. № 3. P. 255-262.
  16. Samani A.A., Yakar S., LeRoith D. et al. The role of the IGF system in cancer growth and metastasis: overview and recent insights // Endocr. Rev. 2007. V. 28. № 1. P. 20-47.
  17. Davison Z., de Blacquière G.E., Westley B.R., May F.E. Insulin-like growth factor-dependent proliferation and survival of triple-negative breast cancer cells: implications for therapy // Neoplasia. 2011. V. 13. № 6. P. 504-515.